| DCE-MRI parameters | TNBC (%) | Non-TNBC (%) | P value |
|---|
| FGT | | | 0.104 |
| A/almost entirely fatty | 12 | 0 | |
| B/scattered FGT | 56 | 44 | |
| C/heterogenous FGT | 32 | 48 | |
| D/extreme FGT | 0 | 8 | |
| BPE | | | 0.264 |
| Minimal | 40 | 56 | |
| Mild | 36 | 36 | |
| Moderate | 24 | 8 | |
| Type of lesion enhanced | | | 0.866 |
| Focus | 9.3 | 12.5 | |
| Mass | 60.5 | 56.3 | |
| NME | 30.2 | 31.3 |
| Mass associated with NME | | | 0.185 |
| Associated | 32 | 16 | |
| Non-associated | 68 | 84 | |
| Mass/shape | | | 0.008 |
| Oval | 7.7 | 7.4 | |
| Round | 30.8 | 3.7 | |
| Irregular | 61.5 | 88.9 | |
| Mass/margin | | | |
| Circumscribed | 30.8 | 11.1 | |
| Non-circumscribed (irregular or spiculated) | 69.2 | 88.9 | 0.078 |
| Mass/internal enhancement | | | 0.001 |
| Homogenous | 23.1 | 70.4 | |
| Heterogenous | 30.8 | 22.2 | |
| Rim enhancement | 46.2 | 7.4 | |
| NME/distribution | | | 0.833 |
| Focal | 30.8 | 40 | |
| Linear | 23.1 | 13.3 | |
| Segmental | 15.4 | 26.7 | |
| Regional | 15.4 | 13.3 | |
| Diffuse | 15.4 | 6.7 | |
| NME/internal enhancement | | | 0.450 |
| Homogenous | 46.2 | 26.7 | |
| Heterogenous | 30.8 | 53.3 | |
| Clumped | 23.1 | 20 | |
| T2 signal intensity | | | < 0.001 |
| High | 62.8 | 16.7 | |
| Low | 34.9 | 79.2 | |
| Indistinct | 2.3 | 4.2 | |
| T2 STIR signal intensity | | | < 0.001 |
| High | 86.0 | 35.4 | |
| Low | 11.6 | 60.4 | |
| Indistinct | 2.3 | 4.2 | |
| Axillary lymph nodes | | | 0.563 |
| Non-specific/not pathological | 28.0 | 32 | |
| Pathological | 72.0 | 68 | |
| K. curve | | | 0.673 |
| Type I: persistent | 16.7 | 16.2 | |
| Type II: plateau | 38.9 | 29.7 | |
| Type III: washout | 44.4 | 54.1 | |
